Ulta Beauty topped second-quarter earnings and revenue forecasts and expanded its fiscal 2026 share repurchase plan to $1.8 billion, underscoring management conviction in the stock despite decelerating comparable sales.
- Diluted EPS of $6.55 beat the $6.17 consensus by 6.2%, rising 13.3% year over year from $5.78
- Net sales of $3.03 billion exceeded the $2.98 billion estimate, up 8.9% from the prior-year period
- FY2026 buyback authorization raised to $1.8 billion from $1.5 billion; $791 million already deployed
Lead
Ulta Beauty (ULTA) posted diluted earnings per share of $6.55 for the second quarter of fiscal 2026, ended August 1, 2026, clearing the Wall Street consensus of $6.17 and advancing 13.3% from the year-earlier $5.78. Net sales reached $3.03 billion, up 8.9% year over year and ahead of the $2.98 billion analyst estimate, as the specialty beauty retailer reported comparable-store sales growth of 3.8% and expanded its loyalty program to roughly 47 million active members.Why Did Ulta Outperform in a Softening Consumer Environment?
Ulta's second-quarter beat reflects the continued resilience of the prestige beauty category, where trade-up behavior and repeat-purchase loyalty have insulated the segment from the broader slowdown in discretionary spending. Comparable sales growth of 3.8%, while decelerating from the 6.7% recorded in the second quarter of fiscal 2025, was underpinned by higher average transaction values and sustained demand in fragrance, skincare, and prestige cosmetics. The 47-million-member loyalty base reinforces purchase frequency and provides the company with a durable demand floor that most specialty retailers lack.
What Does the Buyback Expansion Signal About Management Confidence?
Ulta raised its fiscal 2026 share repurchase authorization to $1.8 billion from the prior $1.5 billion, having already deployed $791 million through the first half of the fiscal year. The authorization increase marks the second expansion of the buyback program in fiscal 2026 - the company had already lifted the target from $1.0 billion to $1.5 billion following the first quarter - signaling that management views the stock's current valuation as an attractive entry point. Capital expenditures of $139.5 million in the first six months supported new store openings, relocations, remodels, and technology investments. Cash and short-term investments totaled $213.5 million at the close of the quarter.
Guidance Raised Across All Key Lines
Full-year fiscal 2026 guidance moved higher on every major metric. Ulta now projects net sales growth of 6.7% to 7.2%, compared with the prior range of 6.0% to 7.0%, with comparable-store sales growth of 3.2% to 3.7% versus the earlier 2.5% to 3.5% band. Operating income growth guidance was lifted to 8.3%-9.3% from 6.5%-9.0%, and diluted EPS guidance advanced to $28.70-$29.00 from the prior $28.36-$28.80. The midpoint of the new range, at $28.85, sits narrowly above the analyst consensus of $28.78.
Market Reaction
Shares declined approximately 3.4% in after-hours trading despite the beat and guidance raise, reflecting investor attention to the deceleration in comparable-store sales growth rather than the headline numbers. The response is consistent with broader market pricing across specialty retail, where expectations have been calibrated for acceleration; solid-but-moderating execution at current multiples tends to disappoint even when absolute results surpass consensus.
Outlook
Ulta Beauty enters the second half of fiscal 2026 with raised full-year targets, an expanded buyback program, and a loyalty base that continues to grow in scale. The principal investor focus will center on the durability of comparable-sales momentum: the deceleration from 6.7% to 3.8% year over year raises questions about whether the prestige beauty category retains enough pricing power to sustain the upper end of the new guidance range if the consumer backdrop softens further. The $1.8 billion buyback authorization - more than half deployed with two quarters remaining - positions ULTA as a consistent buyer of its own shares through fiscal year-end, providing structural support to earnings per share even if top-line growth moderates.





